Form 4: Catalyst Pharmaceuticals Executive Sells Shares for Personal Reasons

Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals, sold 30,423 shares of common stock at $22.89 per share on March 3, 2025, for personal reasons.

Summary

• On March 3, 2025, Jeffrey Del Carmen, the Chief Commercial Officer of Catalyst Pharmaceuticals, sold 30,423 shares of the company's common stock.
• The sale was executed at a price of $22.89 per share.
• The transaction was reported in a Form 4 filing with the Securities and Exchange Commission.
• The shares were sold for personal reasons and not due to any disagreement with the company.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is described as being for personal reasons and not indicative of a negative outlook on the company.

Management Comments

• Shares were sold for personal reasons and not as a result of any disagreement with the Company.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors to gauge insider sentiment about the company's future prospects. However, in this case, the executive stated the sale was for personal reasons.

Stakeholder Impact

• The sale of shares by a high-ranking officer could cause some short-term uncertainty among shareholders, but the stated reason of 'personal reasons' may mitigate concerns.

Key Dates